Atrial fibrillation (AF) is the most frequent arrhythmia in the general population and is associated not only with significant morbidity and mortality but also adversely impacts quality of life. 1, 2 Patient discomfort due to arrhythmia is not just limited to arrhythmic events. Anxiety derived from fear of a new episode is frequent in patients with paroxysmal AF, in some cases becoming more limiting than the arrhythmia itself. The current therapy aiming to control AF-related symptoms is mainly based on anti-arrhythmic drugs and catheter ablation of the pulmonary veins. 3 Despite the significant improvement in this field in past decades, symptom control remains unsatisfactory in a significant proportion of cases. It has been shown that psychological factors such as anxiety, depression or stress increases the recurrence rate of AF episodes after pulmonary vein ablation. 4 It has recently been shown that a stressful lifestyle, such as job strain, significantly increases the risk of AF. 5 Alternative therapies that are focused on the psychosocial aspects of the disease have been shown to reduce the burden of arrhythmia and improve quality of life. Lakkireddy et al. have described how a programmed yoga training reduces the burden of arrhythmia in patients with paroxysmal AF. 6 Lomuscio et al. have shown a similar effect with acupuncture in persistent AF. 7 A positive influence in cardiac autonomic function and a reduction of symptoms of depression and anxiety seem to justify this protective effect. Even if evidence of the relationship between anxiety, depression and AF is growing, some pieces of this puzzle are missing.
In the current issue of the journal Fenger-Gron et al. describe the results of a nationwide registry study in Danish initiating antidepressant treatment. 8 Assuming the start of this therapy as a diagnosis of depression, the authors found that these patients presented with more than a threefold increased risk of AF compared to a reference group randomly sampled among all Danish citizens matched for risk factors. The authors used the time of initiating antidepressant therapy as the time landmark for the analysis, considering depression as the condition in the previous 30 days before starting therapy. After that, patients were considered correctly treated for depression. With this approach the authors evaluated the evolution of the risk of AF during time, showing that the risk of AF was higher when patients were untreated for depression and how this risk was persistently attenuated over the following 12 months. The results of the study are important for two reasons. First, it provides further evidence that the relationship of AF and psychosocial status is bidirectional: not only symptomatic paroxysms produce psychosocial discomfort but also psychosocial discomfort increases the arrhythmic episodes. Second, these results suggest that medical treatment for depression reduces the risk of AF.
However, these conclusions should not yet be considered definitive, as some methodological aspects of the study deserve further considerations. Even if the association with a higher AF risk in patients with untreated depression seems to be well established, the relationship between these two entities seems complex and not yet completely understood. The study design does not permit us to exclude that AF episodes before the beginning of antidepressant therapy have influenced moodiness and psychosocial status in the patient, thus precipitating the diagnosis of depression. Further research is needed before definitive conclusions of causality can be extracted in a complex connection with the multiple mechanisms potentially implicated. Moreover, we cannot ignore that compared with the control group patients starting antidepressant therapy were evaluated in a sensitive period of their lives, with a recent diagnosis of a dreaded disease (depression). Therefore, they are not only in a stressful vital period but also in a period with close contact with the health system. In this regard, multiple psychotropic drugs require serial ECG monitoring to exclude potential cardiac side effects; physician visits are more frequent and, hence, the diagnosis of AF is more probably made in the weeks around the depression diagnosis, progressively to decrease in the succeeding months. This fact could explain that the higher risk of AF occurs in the 4 weeks before starting therapy, matching with the maximum pretreatment medical contact, and also the decrease in the successive 2 weeks, even when depression remains untreated.
In conclusion, the study of Fenger-Gron et al. confirm the association between sadness and AF. However, further studies are needed to understand completely the mechanisms of this intricate relationship. This study represents a further step in the correct direction: the integrated care approach of AF looking beyond the 12-lead ECG or a single organ disease.
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